Considering investing in medical supplies stocks? While the best medical supplies stocks depend on your portfolio and investment goals, we've identified some medical supplies stocks that are worth keeping an eye on in the health sector. Keep reading to learn more about medical supplies stocks and how to start investing.
We round up a selection of stocks in or related to the health industry, weighting the list more heavily towards popular mid- and large-cap stocks.
| Best stock | 1-year return | Market cap | Exchange | Volume | Buy on Questrade |
|---|---|---|---|---|---|
| The Cooper Companies (COO.US) | 5.95% | $13.7 billion (USD) | NASDAQ | 1,931,665 | Buy now |
| N/A (BAX.US) | 14.74% | (data unavailable) | N/A | 5,784,594 | Buy now |
| Hologic (HOLX.US) | (data unavailable) | $17 billion (USD) | NASDAQ | (data unavailable) | Buy now |
| Dentsply Sirona (XRAY.US) | -0.45% | $2.8 billion (USD) | NASDAQ | 5,505,000 | Buy now |
| Teleflex Incorporated (TFX.US) | 20.26% | $6.1 billion (USD) | NYSE | 1,301,200 | Buy now |
| ResMed (RMD.US) | (data unavailable) | $32.5 billion (USD) | NYSE | (data unavailable) | Buy now |
| Intuitive Surgical (ISRG.US) | -20.46% | $126.5 billion (USD) | NASDAQ | 2,581,069 | Buy now |
| Alcon (ALC.US) | -18.62% | $34.2 billion (USD) | NYSE | 1,712,858 | Buy now |
| Johnson-and-Johnson (JNJ.US) | 49.82% | $620.8 billion (USD) | NYSE | 4,302,658 | Buy now |
The health industry is affected by a range of complex factors such as trade policies, regulations, and fluctuating supply and demand. So when considering medical supplies stocks to buy, it's important that you have access to vital information about a company's financial health, leadership team, and market positioning.
Also keep in mind that, while volatility can be ideal for day traders, long-term investors will want to look for stocks to offer steadier gains over time.
A lot of factors go into picking the best medical supplies stocks. Stock performance can be impacted by factors like market conditions, company decisions and global events. Plus, what may be a strong medical supplies stock investment for one person might not be suitable for another.
That said, we rounded up this list of popular medical supplies stocks in or related to the health industry to help narrow down your options:
Keep in mind that this is not a "best" list or a recommendation. It highlights some medical supplies stocks for informational purposes only and does not indicate past or future performance or investment advice. We do not guarantee any investment performance.
We've outlined detailed company and stock performance details for each medical supplies stock below. Keep reading to decide if any of these companies are the right investment for you.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical.
The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia.
| Closing stock price | $73.32 |
|---|---|
| Market Capitalization | $13.7 billion |
| Gross profit (TTM) | $2.8 billion |
| Profit margin | 5.57% |
| Revenue (TTM) | $4.2 billion |
| Earnings per share (TTM) | $1.18 |
| 52-week stock price range | $58.89 – $89.83 |
N/A. .
.
| Closing stock price | N/A27.01 |
|---|
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.
The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth.
| Market Capitalization | $17 billion |
|---|---|
| Gross profit (TTM) | $2.5 billion |
| Profit margin | 13.18% |
| Revenue (TTM) | $4.1 billion |
| Earnings per share (TTM) | $2.41 |
| 52-week stock price range | $63.19 – $76.07 |
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare.
The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering.
| Closing stock price | $13.17 |
|---|---|
| Market Capitalization | $2.8 billion |
| Gross profit (TTM) | $1.8 billion |
| Profit margin | -17.06% |
| Revenue (TTM) | $3.7 billion |
| Earnings per share (TTM) | -$3.04 |
| 52-week stock price range | $9.41 – $14.76 |
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand.
It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters.
| Closing stock price | $138.89 |
|---|---|
| Market Capitalization | $6.1 billion |
| Gross profit (TTM) | $1.2 billion |
| Profit margin | -47.43% |
| Revenue (TTM) | $2.1 billion |
| Earnings per share (TTM) | $0.06 |
| 52-week stock price range | $99.63 – $144.19 |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software.
It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution.
| Market Capitalization | $32.5 billion |
|---|---|
| Gross profit (TTM) | $3.4 billion |
| Profit margin | 27.44% |
| Revenue (TTM) | $5.5 billion |
| Earnings per share (TTM) | $10.42 |
| 52-week stock price range | $180.27 – $291.57 |
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.
The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights.
| Closing stock price | $373.71 |
|---|---|
| Market Capitalization | $126.5 billion |
| Gross profit (TTM) | $7.4 billion |
| Profit margin | 28.45% |
| Revenue (TTM) | $11 billion |
| Earnings per share (TTM) | $8.72 |
| 52-week stock price range | $328.57 – $603.88 |
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care.
It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.
| Closing stock price | $69.54 |
|---|---|
| Market Capitalization | $34.2 billion |
| Gross profit (TTM) | $6 billion |
| Profit margin | 7.70% |
| Revenue (TTM) | $10.6 billion |
| Earnings per share (TTM) | $1.67 |
| 52-week stock price range | $61.84 – $89.97 |
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech.
The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.
| Closing stock price | $256.98 |
|---|---|
| Market Capitalization | $620.8 billion |
| Gross profit (TTM) | $66.7 billion |
| Profit margin | 21.48% |
| Revenue (TTM) | $97.9 billion |
| Earnings per share (TTM) | $8.71 |
| 52-week stock price range | $166.22 – $274.90 |
Compare special offers, low fees and a wide range of investment options among popular trading platforms in Canada. Note that the dollar amounts in the table below are in CAD.
To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score, the better the platform—it's that simple.
Learn how to buy SpaceX stock in Canada and see stock performance history over time.
We break down which companies hold Ethereum, why they’re doing it and what ETH treasuries mean for markets and investors.
Want to invest in the Euro Stoxx 50 in Canada? Explore investment platforms and popular Euro Stoxx 50 index funds.
How Wealthsimple Predict works and how you can potentially use it to make money trading on real-world events.
Compare Wealthsimple and Moomoo side-by-side to decide where to trade stocks, ETFs and more.
Find out the key differences between the Nasdaq Composite and the Nasdaq 100.
Here’s how the Nasdaq and NYSE are different and what you need to know before investing on either exchange.
Taking a chunk of your retirement savings to buy an annuity can provide peace of mind in your golden years. Find out how.
These are the best renewable energy stocks to buy now in Canada.
Finder’s unique algorithm found the 20 best TSX stocks to buy right now.
Comprehensive guide on blockchain stock investing, benefits, risks, main stocks, blockchain ETFs, and more.
Find out how to invest in the S&P 500 in Canada—one of the world’s most popular stock indices—to diversify your portfolio.
Interactive Brokers makes it easy for Canadian investors to access global exchanges with competitive rates and fees.